Economic model estimates cost-effectiveness of corneal cross-linking for keratoconus treatment in the US, suggesting broad applicability.
Aim To optimize the real-world applicability of a health economic model estimating the cost-effectiveness of corneal cross-linking for the treatment of keratoconus in the United States.
No takes yet. Share an insight, caveat, or question.
Rapuano et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: